Cash Flow Glenmark Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
569.00
868.00
1,441.00
1,382.00
1,096.00
1,300.00
Adjustment
1,009.00
1,471.00
787.00
644.00
636.00
329.00
Changes In working Capital
-796.00
-1,074.00
-561.00
-385.00
127.00
136.00
Cash Flow after changes in Working Capital
782.00
1,265.00
1,667.00
1,641.00
1,859.00
1,766.00
Cash Flow from Operating Activities
-265.00
625.00
1,108.00
1,131.00
1,392.00
1,324.00
Cash Flow from Investing Activities
4,386.00
-515.00
-315.00
-661.00
-773.00
-882.00
Cash Flow from Financing Activities
-3,906.00
-77.00
-520.00
-441.00
-444.00
-738.00
Net Cash Inflow / Outflow
215.00
32.00
272.00
27.00
174.00
-297.00
Opening Cash & Cash Equivalents
1,443.00
1,410.00
1,138.00
1,110.00
936.00
1,233.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1,658.00
1,443.00
1,410.00
1,138.00
1,110.00
936.00
Compare Cash Flow Results of Glenmark Pharma
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
569.19
2399.36
-1,830.00
-76.28%
Adjustment
1009.81
212.2
797.00
375.88%
Changes In working Capital
-796.95
20.42
-816.00
-4002.79%
Cash Flow after changes in Working Capital
782.05
2631.98
-1,849.00
-70.29%
Cash Flow from Operating Activities
-265.44
2152.45
-2,417.00
-112.33%
Cash Flow from Investing Activities
4386.82
-2080.52
6,466.00
310.85%
Cash Flow from Financing Activities
-3906.13
5.27
-3,911.00
-74220.11%
Net Cash Inflow / Outflow
215.24
77.19
138.00
178.84%
Opening Cash & Cash Equivalents
1443.03
304.82
1,139.00
373.40%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1658.27
382.01
1,276.00
334.09%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -142.44% vs -43.59% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-265.44
625.39
-142.44%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
